AMGN CIK: 318154

Amgen Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
billions USD
FY21:
9.26
FY22:
9.72
FY23:
8.47
FY24:
11.5
FY25:
9.96
Change from FY21 to FY25
billions USD
FY21:
0.73
FY22:
−6.04
FY23:
−26.2
FY24:
−1.05
FY25:
−1.94
Change from FY21 to FY25
billions USD
FY21:
−8.27
FY22:
−4.04
FY23:
21.0
FY24:
−9.42
FY25:
−10.9
billions USD
FY21:
1.72
FY22:
−0.36
FY23:
3.32
FY24:
1.03
FY25:
−2.84
(positive)
Change from FY21 to FY25
billions USD
FY21:
8.38
FY22:
8.79
FY23:
7.36
FY24:
10.4
FY25:
8.10

All amounts in billions USD Data source:SEC EDGAR